Want to see IN:KRONOX full AI Analyst Report?
Kronox Lab Sciences Limited (KRONOX) Stock Statistics & Valuation Metrics
Total Valuation
Kronox Lab Sciences Limited has a market cap or net worth of INR 6.98B. The enterprise value is INR 3.15B.
- Market Cap
- INR 6.98B
- Enterprise Value
- INR 3.15B
Share Statistics
Kronox Lab Sciences Limited has 37,104,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 37,104,000
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
Kronox Lab Sciences Limited’s return on equity (ROE) is 0.24 and return on invested capital (ROIC) is 20.29%.
- Return on Equity (ROE)
- 0.24
- Return on Assets (ROA)
- 0.22
- Return on Invested Capital (ROIC)
- 20.29%
- Return on Capital Employed (ROCE)
- 0.28
- Revenue Per Employee
- 14.46M
- Profits Per Employee
- 3.95M
- Employee Count
- 70
- Asset Turnover
- 0.79
- Inventory Turnover
- 5.56
Valuation Ratios
The current PE Ratio of Kronox Lab Sciences Limited is 24.06. Kronox Lab Sciences Limited’s PEG ratio is 2.09.
- PE Ratio
- 24.06
- PS Ratio
- 6.56
- PB Ratio
- 5.95
- Price to FCF
- 92.56
- Price to Operating Cash Flow
- 65.84
- PEG Ratio
- 2.09
Income Statement
In the last 12 months, Kronox Lab Sciences Limited had revenue of 1.01B and earned 276.60M in profits. Earnings per share was 7.48.
- Revenue
- 1.01B
- Gross Profit
- 546.44M
- Operating Income
- 322.23M
- Pretax Income
- 373.03M
- Net Income
- 276.60M
- EBITDA
- 394.65M
- Earnings Per Share (EPS)
- 7.48
Cash Flow
In the last 12 months, operating cash flow was 104.97M and capital expenditures -30.30M, giving a free cash flow of 74.67M billion.
- Operating Cash Flow
- 104.97M
- Free Cash Flow
- 74.67M
- Free Cash Flow per Share
- 2.01
Dividends & Yields
Kronox Lab Sciences Limited pays an annual dividend of INR 0.50, resulting in a dividend yield of 0.27%
- Dividend Per Share
- INR 0.50
- Dividend Yield
- 0.27%
- Payout Ratio
- 7.19%
- Free Cash Flow Yield
- 1.08%
- Earnings Yield
- 4.13%
Stock Price Statistics
- Beta
- 1.23
- 52-Week Price Change
- 24.94%
- 50-Day Moving Average
- 193.13
- 200-Day Moving Average
- 149.34
- Relative Strength Index (RSI)
- 44.35
- Average Volume (3m)
- 62.11K
Important Dates
Kronox Lab Sciences Limited upcoming earnings date is Nov 17, 2026, TBA (Not Confirmed).
- Last Earnings Date
- Aug 12, 2026
- Next Earnings Date
- Nov 17, 2026
- Ex-Dividend Date
- Aug 08, 2025
Financial Position
Kronox Lab Sciences Limited as a current ratio of 7.60, with Debt / Equity ratio of 1.38%
- Current Ratio
- 7.60
- Quick Ratio
- 6.80
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- -0.03
- Interest Coverage Ratio
- 282.66
Taxes
In the past 12 months, Kronox Lab Sciences Limited has paid 96.43M in taxes.
- Income Tax
- 96.43M
- Effective Tax Rate
- 0.26
Enterprise Valuation
Kronox Lab Sciences Limited EV to EBITDA ratio is 17.49, with an EV/FCF ratio of 92.56.
- EV to Sales
- 6.56
- EV to EBITDA
- 17.49
- EV to Free Cash Flow
- 92.56
- EV to Operating Cash Flow
- 65.84
Balance Sheet
Kronox Lab Sciences Limited has INR 487.41M in cash and marketable securities with INR 0.00 in debt, giving a net cash position of INR 487.41M billion.
- Cash & Marketable Securities
- INR 487.41M
- Total Debt
- INR 0.00
- Net Cash
- INR 487.41M
- Net Cash Per Share
- INR 13.14
- Tangible Book Value Per Share
- INR 31.30
Margins
Gross margin is 51.29%, with operating margin of 31.42%, and net profit margin of 27.13%.
- Gross Margin
- 51.29%
- Operating Margin
- 31.42%
- Pretax Margin
- 36.61%
- Net Profit Margin
- 27.13%
- EBITDA Margin
- 37.51%
- EBIT Margin
- 35.52%
Analyst Forecast
The average price target for Kronox Lab Sciences Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 6.07%
- EPS Growth Forecast
- 11.62%
Scores
- Smart Score
- ―
- AI Score
- 79